secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001140361-24-040508
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.05, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano cuts workforce 45%, lowers revenue guidance to $32-36M, CFO departs
---------------------------------------------------------------------------

- Reduction of ~84 employees (45% of workforce); expects $25-30M annual cost savings starting Q4 2024.
- Revenue guidance reduced to $32-36M from $36-40M due to fewer OGM instrument placements.
- CFO Gülsen Kama leaving effective Sep 18; CEO Erik Holmlin appointed principal financial officer.
- Restructuring charges estimated at $0.5-1.0M, substantially complete by Oct 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124040508/0001140361-24-040508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124040508/ny20035639x1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-040508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer